decisionhealth Newsletters, Part B News - 2001 Issue 4 (April)
Carriers ordered to report drug pricing methods
Subscribe or sign in to view the full article.
Article Overview
This article discusses a Medicare payment oversight effort focused on how carriers determine pricing for physician-administered drugs. It explains the government’s request for information, the stated concerns about pricing consistency and uniformity, and the broader policy context around drug reimbursement reform. The piece is relevant to billing professionals, oncology practices, and others who track Medicare Part B drug payment policy.
Why This Topic Matters
Drug payment methodology affects reimbursement, practice revenue, and compliance for offices that administer Medicare-covered drugs. Understanding the policy scrutiny helps providers and billing staff anticipate changes in reporting, pricing oversight, and reimbursement administration.
What You Will Learn
- Why Medicare drug pricing methods are being reviewed
- What information carriers were asked to provide
- How prior reform efforts and stakeholder opposition shaped the issue
- Which provider groups are most affected by the pricing debate
Who Should Read This
- Medical coders
- Billing staff
- Practice managers
- Oncology practices
- Healthcare compliance staff
- Medicare reimbursement professionals
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com